Bistola, Vasiliki
Parissis, John
Foukarakis, Emmanouil
Valsamaki, Pipitsa N.
Anastasakis, Aris
Koutsis, Georgios
Efthimiadis, Georgios
Kastritis, Efstathios http://orcid.org/0000-0001-8191-5832
Article History
Accepted: 30 November 2020
First Online: 15 January 2021
Compliance with ethical standards
:
: Dr. Bistola reports honoraria for lectures from Novartis, Pfizer, and Servier. Dr. Parissis reports horonaria for lectures and advisory boards from Novartis, Pfizer, Servier, Orion Pharma, and Roche Diagnostics. Dr. Kastritis has received honoraria for lectures and advisory boards from Amgen, Genesis Pharma, Janssen, Takeda, Pfizer, and research funding from Amgen and Janssen. Dr. Foukarakis reports honoraria for lectures and advisory boards from Pfizer, Menarini and Bayer. G. Koutsis has received research grants from Genesis Pharma and Teva, consultation fees, advisory boards, and honoraria from Genzyme, Genesis Pharma, Teva, and Novartis. Drs. Valsamaki, Anastasakis, and Efthimiadis report honoraria from Pfizer.
: All authors agree to publish the present manuscript in its current form.